Literature DB >> 15847995

Topical drug classification.

Lucinda Buhse1, Richard Kolinski, Benjamin Westenberger, Anna Wokovich, John Spencer, Chi Wan Chen, Saleh Turujman, Mamta Gautam-Basak, Gil Jong Kang, Arthur Kibbe, Brian Heintzelman, Eric Wolfgang.   

Abstract

Current definitions of lotions, gels, creams and ointments vary depending on literature source, market history or traditional use. This often leads to confusion when deciding which dosage form to prescribe and/or purchase. The existing classification of topical dosage forms needs to be re-examined to ensure that definitions for different dosage forms are based on consistent scientific principles and that dosage forms can be distinguished from one another. The purpose of this study is to obtain a scientifically based, systematic classification of dosage forms for topical drugs. A variety of prescription and over-the-counter topical products currently marketed as lotions, gels, creams, and ointments are evaluated using different techniques including rheology (viscosity and shear rate versus shear stress), loss on drying (LOD), specific gravity, surface tension, thermogravimetric analysis (TGA), water absorption, dilution properties, microscopic evaluation, transmittance of visible light, appearance and composition. Rheology is the most discriminating property separating creams and lotions. Water plus volatiles (as measured by LOD) and composition separate ointments and creams. Composition and thermal behavior separate gels from the other dosage forms. Based on these findings, new definitions and a decision tree are presented to assist in the determination of the appropriate nomenclature for a topical dosage form.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15847995     DOI: 10.1016/j.ijpharm.2005.01.032

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  8 in total

1.  Enhanced epidermal localization of topically applied steroids using SPACE™ peptide.

Authors:  Sunny Kumar; Ming Chen; Aaron C Anselmo; John A Muraski; Samir Mitragotri
Journal:  Drug Deliv Transl Res       Date:  2015-10       Impact factor: 4.617

Review 2.  Generic development of topical dermatologic products: formulation development, process development, and testing of topical dermatologic products.

Authors:  Rong-Kun Chang; Andre Raw; Robert Lionberger; Lawrence Yu
Journal:  AAPS J       Date:  2012-10-09       Impact factor: 4.009

3.  Deformable Liposomal Hydrogel for Dermal and Transdermal Delivery of Meloxicam.

Authors:  Zhang Julia Zhang; Tomasz Osmałek; Bozena Michniak-Kohn
Journal:  Int J Nanomedicine       Date:  2020-11-24

4.  Nanostructured Non-Ionic Surfactant Carrier-Based Gel for Topical Delivery of Desoximetasone.

Authors:  Parinbhai Shah; Benjamin Goodyear; Nirali Dholaria; Vinam Puri; Bozena Michniak-Kohn
Journal:  Int J Mol Sci       Date:  2021-02-03       Impact factor: 5.923

5.  Novel Fusidic Acid Cream Containing Metal Ions and Natural Products against Multidrug-Resistant Bacteria.

Authors:  Hani Naseef; Yousef Sahoury; Mohammad Farraj; Moammal Qurt; Abdallah D Abukhalil; Nidal Jaradat; Israr Sabri; Abdullah K Rabba; Mahmmoud Sbeih
Journal:  Pharmaceutics       Date:  2022-08-05       Impact factor: 6.525

Review 6.  Quality by Design: Development of the Quality Target Product Profile (QTPP) for Semisolid Topical Products.

Authors:  Sarika Namjoshi; Maryam Dabbaghi; Michael S Roberts; Jeffrey E Grice; Yousuf Mohammed
Journal:  Pharmaceutics       Date:  2020-03-23       Impact factor: 6.321

7.  General practice recommendations for the topical treatment of psoriasis: a modified-Delphi approach.

Authors:  Diamant Thaçi; Pablo de la Cueva; Andrew E Pink; Ahmad Jalili; Siegfried Segaert; Kasper F Hjuler; Piergiacomo Calzavara-Pinton
Journal:  BJGP Open       Date:  2020-12-15

Review 8.  Vehicles for Drug Delivery and Cosmetic Moisturizers: Review and Comparison.

Authors:  Tanya M Barnes; Dalibor Mijaljica; Joshua P Townley; Fabrizio Spada; Ian P Harrison
Journal:  Pharmaceutics       Date:  2021-11-26       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.